This review highlights risk factors and occurrences of invasive fungal diseases in recipients of allogeneic hematopoietic stem cells, suggesting ongoing risks despite antifungal prophylaxis.
Allogeneic hematopoietic stem cell transplantation is a standard treatment option for a variety of hematological disorders. In recent years, there has been observed an increase in transplantation activity worldwide as well as in use of alternative donors. Despite introduction of antifungal prophylaxis, recipients of allogeneic hematopoietic stem cells still have a high risk of invasive fungal disease.This review represents risk factors, frequency and structure of invasive fungal disease in this category of patients.
No takes yet. Share an insight, caveat, or question.
Mironova et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: